큐라미스, MaxCyte사와 전략적 플랫폼 계약 체결 관리자 │ 2022-12-05 HIT 2427 |
---|
https://www.globenewswire.com/news-release/2022/12/05/2567044/0/en/MaxCyte-Signs-Strategic-Platform-License-with-Curamys-to-Enable-Cell-Gene-Therapies-for-the-Treatment-of-Rare-Intractable-Diseases.htmlhttps://markets.businessinsider.com/news/stocks/maxcyte-curamys-in-strategic-platform-license-deal-1031952309 |
이전글 | 강스템, 큐라미스와 유전자세포치료제 CDMO 계약 |
---|---|
다음글 | 다음글이 없습니다. |